Actively Recruiting
Reduced Time Interval for Implant Placement After Extraction Socket Preservation Using the Vega Plus Implants
Led by Universidad Catolica Santiago de Guayaquil · Updated on 2026-05-01
40
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
U
Universidad Catolica Santiago de Guayaquil
Lead Sponsor
K
Klockner Implant System
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized controlled clinical trial aims to evaluate whether reducing the healing interval for implant placement after extraction socket preservation improves clinical and radiographic outcomes compared with the conventional waiting period. Participants requiring single-tooth extraction and implant therapy will be randomly assigned to implant placement either 4 months or 6 months after ridge preservation using the Vega Plus implant system (Klockner). Clinical and radiographic assessments will be performed at baseline and during follow-up visits. The primary outcome will be the mean change in horizontal alveolar ridge width measured using cone-beam computed tomography (CBCT). Secondary outcomes will include vertical bone height changes measured on CBCT, implant stability measured using resonance frequency analysis (ISQ values), marginal bone level changes assessed on standardized periapical radiographs, and postoperative pain assessed using the Visual Analog Scale (VAS). The results of this study may contribute to optimizing treatment timing and improving efficiency in implant dentistry while maintaining favorable clinical outcomes.
CONDITIONS
Official Title
Reduced Time Interval for Implant Placement After Extraction Socket Preservation Using the Vega Plus Implants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age: ≥ 18 years.
- Good general health.
- Need of extraction of incisors, canines or premolars due to carious lesion, endodontic complication, root fracture or prosthetic reason.
- Presence of three intact socket walls after tooth extraction with a defect of 50% or more of the buccal wall.
- Need of single-tooth implant treatment, with presence of adjacent teeth and opposing occluding teeth (for measurement stent indexing).
- Enough available bone assessed on CBCT to place implants with 3.6 mm diameter and 10 mm in length.
- Periodontal health in intact or reduced periodontium.
- Full-mouth plaque and bleeding scores < 20%.
- Able and willing to follow study procedures and instructions.
You will not qualify if you...
- < 18 years.
- Compromised health. Existence of any systemic condition such as uncontrolled diabetes mellitus, cancer, HIV, disorders that compromise wound healing, chronic high dose steroid therapy, intravenous and oral bisphosphonate therapy, bone metabolic diseases, history of irradiation of the head and neck area, or any other immunosuppressive therapy that would contraindicate oral surgical treatment.
- Absence of any adjacent teeth or the opposing occluding teeth.
- The hopeless tooth is a molar.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Universidad Catolica Santiago de Guayaquil- Carrera de Odontologia de La Ucsg
Guayaquil, Guayas, Ecuador, 090101
Actively Recruiting
Research Team
G
GABRIELA GUADALUPE ZAMBRANO MANZABA, DDS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here